At a Beijing military parade in September 2025, a hot microphone captured Russian President Vladimir Putin telling Chinese President Xi Jinping that advances in biotechnology could allow humans to continuously replace their organs, grow younger, and perhaps even achieve immortality. Xi responded that people may live to 150 years by the end of this century. The exchange was widely dismissed as eccentric small talk between aging heads of state. It was neither eccentric nor small.
Behind Putin's remarks sat a $26 billion Russian state initiative, a team of scientists working toward bioprinted human organs by 2030, and a broader pattern of powerful states and private actors treating human longevity as a strategic priority. As gene therapies, regenerative medicine, and organ replacement technologies move from laboratories toward clinical settings, a question that has received little attention begins to demand serious consideration: what happens to state power when the biological clock that has always constrained political leaders and their institutions starts to slow down?
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.